Magnetic Resonance Imaging in Primary Sclerosing Cholangitis-Current State and Future Directions

被引：17
作者：
Zenouzi, Roman [1 ]
Welle, Christopher L. [2 ]
Venkatesh, Sudhakar K. [2 ]
Schramm, Christoph [1 ,3 ]
Eaton, John E. [4 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany
[2] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[3] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany
[4] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA
来源：
SEMINARS IN LIVER DISEASE | 2019年 / 39卷 / 03期
关键词：
magnetic resonance cholangiopancreatography; magnetic resonance elastography; magnetic resonance imaging; primary sclerosing cholangitis; SURFACE NODULARITY QUANTIFICATION; HIGH SIGNAL INTENSITY; GLOBUS-PALLIDUS; DENTATE NUCLEUS; CONTRAST AGENT; GADOXETIC ACID; CHOLANGIOPANCREATOGRAPHY MRCP; TRANSIENT ELASTOGRAPHY; ALKALINE-PHOSPHATASE; TEXTURE ANALYSIS;
D O I：
10.1055/s-0039-1687853
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by biliary inflammation and fibrosis leading to bile duct strictures, cirrhosis, and carries an increased risk of hepatobiliary malignancies. Magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice in PSC. As an evolving technology, MRI has other potential applications in the care and study of those patients with PSC. In this review, the authors aim to provide a technical overview on MRI/MRCP and related technologies, summarize its contemporary use in PSC, and discuss its evolving role to predict outcomes and look ahead toward emerging MRI technologies relevant to PSC.
引用
收藏
页码：369 / 380
页数：12
相关论文
共 111 条
[1]   Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline [J].
Aabakken, Lars ;
Karlsen, Tom H. .
JOURNAL OF HEPATOLOGY, 2017, 66 (06) :1265-1281
[2]   Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis [J].
Al Mamari, Said ;
Djordjevic, Jelena ;
Halliday, John S. ;
Chapman, Roger W. .
JOURNAL OF HEPATOLOGY, 2013, 58 (02) :329-334
[3]   Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis [J].
Ali, Ahmad Hassan ;
Tabibian, James H. ;
Nasser-Ghodsi, Navine ;
Lennon, Ryan J. ;
DeLeon, Thomas ;
Borad, Mitesh J. ;
Hilscher, Moira ;
Silveira, Marina G. ;
Carey, Elizabeth J. ;
Lindor, Keith D. .
HEPATOLOGY, 2018, 67 (06) :2338-2351
[4]  
[Anonymous], GUT
[5]  
[Anonymous], 2018, ACR MANUAL CONTRAST
[6]  
Arrive L, 2013, Diagn Interv Imaging, V94, P757, DOI 10.1016/j.diii.2013.03.006
[7]   Assessing fracture risk using gradient boosting machine (GBM) models [J].
Atkinson, Elizabeth J. ;
Therneau, Terry M. ;
Melton, L. Joseph, III ;
Camp, Jon J. ;
Achenbach, Sara J. ;
Amin, Shreyasee ;
Khosla, Sundeep .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (06) :1397-1404
[8]   Prediction of Outcome in Acute Lower Gastrointestinal Bleeding Using Gradient Boosting [J].
Ayaru, Lakshmana ;
Ypsilantis, Petros-Pavlos ;
Nanapragasam, Abigail ;
Choi, Ryan Chang-Ho ;
Thillanathan, Anish ;
Min-Ho, Lee ;
Montana, Giovanni .
PLOS ONE, 2015, 10 (07)
[9]   Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions [J].
Babu, Aparna Srinivasa ;
Wells, Michael L. ;
Teytelboym, Oleg M. ;
Mackey, Justin E. ;
Miller, Frank H. ;
Yeh, Benjamin M. ;
Ehman, Richard L. ;
Venkatesh, Sudhakar K. .
RADIOGRAPHICS, 2016, 36 (07) :1987-2006
[10]   Hepatic and extrahepatic malignancies in primary sclerosing cholangitis [J].
Bergquist, A ;
Ekbom, A ;
Olsson, R ;
Kornfeldt, D ;
Lööf, L ;
Danielsson, Å ;
Hultcrantz, R ;
Lindgren, S ;
Prytz, H ;
Sandberg-Gertzén, H ;
Almer, S ;
Granath, F ;
Broomé, U .
JOURNAL OF HEPATOLOGY, 2002, 36 (03) :321-327
12345678910